STERIS plc Cost of Revenue
STERIS plc (STE) reported Cost of Revenue of $808.60 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2026-08-07
- STERIS plc cost of revenue for the quarter ending 2026-06-30 was $808.60M, a 5.96% increase year-over-year.
- STERIS plc cost of revenue for the quarter ending 2025-12-31 was $840.70M, a 10.59% increase year-over-year.
- STERIS plc cost of revenue for the quarter ending 2025-09-30 was $814.40M, a 8.57% increase year-over-year.
- STERIS plc cost of revenue for the quarter ending 2025-06-30 was $763.10M, a 7.92% increase year-over-year.
- STERIS plc cost of revenue for fiscal 2017 was $1.59B.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 6 month as first filed | Cost of Revenue 9 month | Cost of Revenue 9 month as first filed | Cost of Revenue 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $808.60M 10-Q · filed 2026-08-07 | ||||||
| 2025-12-31 | $840.70M 10-Q · filed 2026-02-06 | $1.66B derived: sum of 2 quarters · filed 2026-02-06 | $2.42B 10-Q · filed 2026-02-06 | ||||
| 2025-09-30 | $814.40M 10-Q · filed 2025-11-06 | $1.58B 10-Q · filed 2025-11-06 | |||||
| 2025-06-30 | $763.10M 10-Q · filed 2026-08-07 | ||||||
| 2024-12-31 | $760.20M 10-Q · filed 2026-02-06 | $760.24M 10-Q · filed 2025-02-07 | $1.51B derived: sum of 2 quarters · filed 2026-02-06 | $2.22B 10-Q · filed 2026-02-06 | $2.22B 10-Q · filed 2025-02-07 | ||
| 2024-09-30 | $750.10M 10-Q · filed 2025-11-06 | $750.12M 10-Q · filed 2024-11-07 | $1.46B 10-Q · filed 2025-11-06 | $1.46B 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | $707.10M 10-Q · filed 2025-08-07 | $707.07M 10-Q · filed 2024-08-08 | |||||
| 2023-12-31 | $737.70M 10-Q · filed 2025-02-07 | $793.05M 10-Q · filed 2024-02-08 | $1.43B derived: sum of 2 quarters · filed 2025-02-07 | $2.08B 10-Q · filed 2025-02-07 | $2.25B 10-Q · filed 2024-02-08 | ||
| 2023-09-30 | $691.98M 10-Q · filed 2024-11-07 | $748.83M 10-Q · filed 2023-11-07 | $1.35B 10-Q · filed 2024-11-07 | $1.46B 10-Q · filed 2023-11-07 | |||
| 2023-06-30 | $654.38M 10-Q · filed 2024-08-08 | $711.08M 10-Q · filed 2023-08-08 | |||||
| 2022-12-31 | $694.50M 10-Q · filed 2024-02-08 | $1.36B derived: sum of 2 quarters · filed 2024-02-08 | $2.00B 10-Q · filed 2024-02-08 | $2.64B derived: sum of 4 quarters · filed 2024-02-08 | |||
| 2022-09-30 | $668.18M 10-Q · filed 2023-11-07 | $1.31B 10-Q · filed 2023-11-07 | $1.95B derived: sum of 3 quarters · filed 2023-11-07 | $2.62B derived: sum of 4 quarters · filed 2023-11-07 | |||
| 2022-06-30 | $638.69M 10-Q · filed 2023-08-08 | $1.28B derived: sum of 2 quarters · filed 2023-08-08 | $1.95B derived: sum of 3 quarters · filed 2023-08-08 | $2.67B derived: sum of 4 quarters · filed 2023-08-08 | |||
| 2022-03-31 | $639.06M 10-K · filed 2022-05-31 | $1.31B derived: sum of 2 quarters · filed 2023-02-08 | $2.03B derived: sum of 3 quarters · filed 2023-02-08 | $2.57B derived: sum of 4 quarters · filed 2023-02-08 | |||
| 2021-12-31 | $670.86M 10-Q · filed 2023-02-08 | $1.39B derived: sum of 2 quarters · filed 2023-02-08 | $1.93B 10-Q · filed 2023-02-08 | $2.42B derived: sum of 4 quarters · filed 2023-02-08 | |||
| 2021-09-30 | $716.64M 10-Q · filed 2022-11-09 | $1.26B 10-Q · filed 2022-11-09 | $1.75B derived: sum of 3 quarters · filed 2022-11-09 | $2.22B derived: sum of 4 quarters · filed 2022-11-09 | |||
| 2021-06-30 | $542.14M 10-K · filed 2022-05-31 | $1.04B derived: sum of 2 quarters · filed 2022-05-31 | $1.50B derived: sum of 3 quarters · filed 2022-05-31 | $1.93B derived: sum of 4 quarters · filed 2022-05-31 | |||
| 2021-03-31 | $493.71M 10-K · filed 2022-05-31 | $956.78M derived: sum of 2 quarters · filed 2022-05-31 | $1.38B derived: sum of 3 quarters · filed 2022-05-31 | $1.76B derived: sum of 4 quarters · filed 2022-05-31 | |||
| 2020-12-31 | $463.06M 10-K · filed 2022-05-31 | $889.16M derived: sum of 2 quarters · filed 2022-05-31 | $1.27B 10-Q · filed 2022-02-09 | $1.27B 10-Q · filed 2021-02-09 | $1.73B derived: sum of 4 quarters · filed 2022-05-31 | ||
| 2020-09-30 | $426.10M 10-K · filed 2022-05-31 | $807.64M 10-Q · filed 2021-11-08 | $809.46M 10-Q · filed 2020-11-06 | $1.27B derived: sum of 3 quarters · filed 2022-05-31 | $1.71B derived: sum of 4 quarters · filed 2022-05-31 | ||
| 2020-06-30 | $381.55M 10-K · filed 2022-05-31 | $383.36M 10-Q · filed 2020-08-07 | $841.45M derived: sum of 2 quarters · filed 2022-05-31 | $1.28B derived: sum of 3 quarters · filed 2022-05-31 | $1.70B derived: sum of 4 quarters · filed 2022-05-31 | ||
| 2020-03-31 | $459.90M 10-K · filed 2021-05-28 | $458.93M 10-K · filed 2020-05-29 | $902.81M derived: sum of 2 quarters · filed 2021-05-28 | $1.32B derived: sum of 3 quarters · filed 2021-05-28 | $1.71B 8-K · filed 2021-02-09 | ||
| 2019-12-31 | $442.91M 10-K · filed 2021-05-28 | $861.08M derived: sum of 2 quarters · filed 2021-05-28 | $1.25B 10-Q · filed 2021-02-09 | $1.68B derived: sum of 4 quarters · filed 2021-05-28 | |||
| 2019-09-30 | $418.17M 10-K · filed 2021-05-28 | $809.13M 10-Q · filed 2020-11-06 | $1.24B derived: sum of 3 quarters · filed 2021-05-28 | $1.65B derived: sum of 4 quarters · filed 2021-05-28 | |||
| 2019-06-30 | $389.91M 10-K · filed 2021-05-28 | $390.96M 10-Q · filed 2019-08-07 | $823.41M derived: sum of 2 quarters · filed 2021-05-28 | $1.23B derived: sum of 3 quarters · filed 2021-05-28 | $1.63B derived: sum of 4 quarters · filed 2021-05-28 | ||
| 2019-03-31 | $433.50M 8-K · filed 2021-02-09 | $842.74M derived: sum of 2 quarters · filed 2021-02-09 | $1.24B derived: sum of 3 quarters · filed 2021-02-09 | $1.61B 8-K · filed 2021-02-09 | |||
| 2018-12-31 | $409.24M 8-K · filed 2021-02-09 | $803.54M derived: sum of 2 quarters · filed 2021-02-09 | $1.17B derived: sum of 3 quarters · filed 2021-02-09 | $1.60B derived: sum of 4 quarters · filed 2021-02-09 | |||
| 2018-09-30 | $394.30M 8-K · filed 2021-02-09 | $764.00M derived: sum of 2 quarters · filed 2021-02-09 | $1.19B derived: sum of 3 quarters · filed 2021-02-09 | $1.57B derived: sum of 4 quarters · filed 2021-02-09 | |||
| 2018-06-30 | $369.71M 8-K · filed 2021-02-09 | $793.32M derived: sum of 2 quarters · filed 2021-02-09 | $1.18B derived: sum of 3 quarters · filed 2021-02-09 | $1.19B derived: sum of 4 quarters · filed 2021-02-09 | |||
| 2018-03-31 | $423.61M 10-K · filed 2019-05-30 | $807.29M derived: sum of 2 quarters · filed 2019-05-30 | $822.85M derived: sum of 3 quarters · filed 2019-05-30 | $1.53B 8-K · filed 2021-02-09 | |||
| 2017-12-31 | $383.68M 10-K · filed 2019-05-30 | $399.25M derived: sum of 2 quarters · filed 2019-05-30 | $751.44M derived: sum of 3 quarters · filed 2019-05-30 | ||||
| 2017-09-30 | $15.56M derived: 10-K 6 month − 10-K 3 month · filed 2019-05-30 | $367.76M 10-K · filed 2019-05-30 | |||||
| 2017-06-30 | $352.20M 10-K · filed 2019-05-30 | ||||||
| 2017-03-31 | $1.59B 10-K · filed 2019-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |